Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Biofrontera Bioscience Sponsored Study Titled 'Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp' Posted To ClinicalTrials.Gov


Benzinga | Sep 29, 2021 08:37AM EDT

Biofrontera Bioscience Sponsored Study Titled 'Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp' Posted To ClinicalTrials.Gov

https://clinicaltrials.gov/ct2/show/NCT05060237






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC